Skip to main content

Tachyphylaxis

pharmacology

A rapid loss of response that develops within a single session or across closely spaced doses, generally through receptor internalisation rather than the slower adaptations behind ordinary tolerance. The timescale is the distinction: tachyphylaxis emerges while the substance is still acting, and re-dosing tends not to restore the original effect.

Tachyphylaxis is a rapid, acute form of tolerance in which the response to a substance diminishes sharply within a single session or across doses taken in quick succession. Where ordinary tolerance unfolds through repeated use over days or weeks, tachyphylaxis can emerge within minutes to hours — sometimes while the substance is still active.

The term derives from Greek roots meaning swift protection, reflecting the body's rapid defensive response to sustained receptor stimulation. It is related to desensitisation but is not identical: tachyphylaxis describes the observable loss of effect; receptor desensitisation is the cellular mechanism most often responsible.

How it works · its role

The primary mechanism is receptor internalisation. When a receptor is activated repeatedly or continuously, the cell tags it for removal from the surface — a process coordinated by G protein-coupled receptor kinases (GRKs), which phosphorylate the active receptor. This recruits a protein called beta-arrestin, triggering endocytosis: the receptor is drawn inward and temporarily taken out of service.

With fewer surface receptors available, the same dose produces less effect. Recovery depends on how quickly the cell recycles receptors back to the membrane — for many receptor types, a process measured in hours rather than days. During that window, re-dosing tends not to restore the original response.

Relevance to substances & effects

Tachyphylaxis shapes the subjective arc of several substance classes. MDMA is a commonly cited example: attempts to re-dose within a session rarely return the initial emotional intensity, partly because the serotonin-releasing mechanisms that drive that peak become self-limiting as exposure continues.

Stimulants such as amphetamines show similar within-session diminishing returns. Some vasoactive compounds and nasal decongestants follow the same pattern — the target response flattens with repeated application before the substance has cleared the body.

This is why re-dosing to chase a fading peak often fails and tends to increase total exposure without a proportional return in effect.

Tolerance & dependence

Tachyphylaxis is itself a form of acute tolerance, but it sits at the fastest end of the spectrum. Unlike chronic tolerance — which involves lasting changes in receptor density, enzyme activity, and downstream signalling pathways — tachyphylaxis is generally reversible within a single rest period and does not imply permanent neuroadaptation.

Where it touches dependence risk is primarily behavioural: because the effect fades while the substance is still active, it can prompt repeated re-dosing in an attempt to recapture the initial response. Escalating intake within a session increases total exposure without restoring the original effect — a pattern that carries greater significance for substances with narrow safety margins.

AI-generated · not yet verified by a human reviewer

Harm-reduction reference — not medical advice.

Last updated Aug 24, 2026Report an issue